rs199894823
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_030962.4(SBF2):c.1424A>G(p.Gln475Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000297 in 1,614,010 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_030962.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000558 AC: 85AN: 152194Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000346 AC: 87AN: 251456Hom.: 0 AF XY: 0.000412 AC XY: 56AN XY: 135908
GnomAD4 exome AF: 0.000270 AC: 394AN: 1461816Hom.: 1 Cov.: 32 AF XY: 0.000286 AC XY: 208AN XY: 727214
GnomAD4 genome AF: 0.000558 AC: 85AN: 152194Hom.: 0 Cov.: 31 AF XY: 0.000713 AC XY: 53AN XY: 74350
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 4B2 Uncertain:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
The SBF2 c.1424A>G; p.Gln475Arg variant (rs199894823, ClinVar Variation ID: 220352) is reported rarely in individuals with Charcot-Marie-Tooth disease (Volodarsky 2021, Yalcintepe 2021). This variant is found in the general population with an overall allele frequency of 0.03% (90/282862 alleles) in the Genome Aggregation Database (v2.1.1). Computational analyses predict that this variant is deleterious (REVEL: 0.705). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Volodarsky M et al. Comprehensive genetic sequence and copy number analysis for Charcot-Marie-Tooth disease in a Canadian cohort of 2517 patients. J Med Genet. 2021 Apr. PMID: 32376792. Yalcintepe S et al. The Importance of Multiple Gene Analysis for Diagnosis and Differential Diagnosis in Charcot Marie Tooth Disease. Turk Neurosurg. 2021 PMID: 34169998. -
not provided Uncertain:2
- -
A variant of uncertain significance has been identified in the SBF2 gene. The Q475R variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The Q475R variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -
Charcot-Marie-Tooth disease Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.1424A>G (p.Q475R) alteration is located in exon 14 (coding exon 14) of the SBF2 gene. This alteration results from a A to G substitution at nucleotide position 1424, causing the glutamine (Q) at amino acid position 475 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Charcot-Marie-Tooth disease type 4 Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 475 of the SBF2 protein (p.Gln475Arg). This variant is present in population databases (rs199894823, gnomAD 0.07%). This missense change has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease (PMID: 32376792, 34169998). ClinVar contains an entry for this variant (Variation ID: 220352). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SBF2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at